Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Mastocytosis 3Pancreatic Neoplasms 2Recurrence 1Pruritus 1Piebaldism 1Ovarian Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Metastatic Castrate Resistant Prostate Cancer 1Mastocytosis, Systemic 1Gastrointestinal Stromal Tumors 1Gastro-intestinal Stromal Tumours 1Gastro Intestinal Stromal Tumor 1Colorectal Cancer Metastatic 1Blushing 1

Interventions

masitinib 1Tyrosine Kinase Inhibitors 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastro Intestinal Stromal Tumor × masitinib × Clear all
NCT01506336 2018-12-11

Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

AB Science

Phase 2 Completed
44 enrolled

Gastro Intestinal Stromal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡